Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-249,195
Closed -$20.1M 1068
2025
Q4
$20.1M Sell
249,195
-65,182
-21% -$5.24M 0.07% 205
2025
Q3
$25.8M Sell
314,377
-4,291
-1% -$372K 0.1% 167
2025
Q2
$29.1M Buy
318,668
+67,550
+27% +$6.04M 0.12% 135
2025
Q1
$23M Buy
251,118
+9,627
+4% +$840K 0.11% 165
2024
Q4
$20.6M Sell
241,491
-7,253
-3% -$636K 0.09% 164
2024
Q3
$21.8M Sell
248,744
-26,096
-9% -$2.2M 0.12% 147
2024
Q2
$21.7M Buy
274,840
+26,462
+11% +$2.17M 0.11% 147
2024
Q1
$22.4M Buy
248,378
+5,332
+2% +$486K 0.11% 137
2023
Q4
$21.4M Buy
243,046
+40,312
+20% +$3.36M 0.12% 134
2023
Q3
$17.1M Buy
202,734
+108,977
+116% +$9.84M 0.1% 152
2023
Q2
$9.27M Sell
93,757
-19,487
-17% -$1.83M 0.06% 208
2023
Q1
$10.9M Sell
113,244
-18,266
-14% -$1.69M 0.07% 202
2022
Q4
$12M Sell
131,510
-13,481
-9% -$1.15M 0.07% 221
2022
Q3
$11.5M Buy
144,991
+89,759
+163% +$7.6M 0.06% 232
2022
Q2
$4.6M Buy
55,232
+33,855
+158% +$2.79M 0.02% 505
2022
Q1
$1.76M Buy
21,377
+10,239
+92% +$802K 0.01% 712
2021
Q4
$834K Buy
+11,138
New +$836K ﹤0.01% 603
2020
Q3
Sell
-4,860
Closed -$296K 456
2020
Q2
$296K Sell
4,860
-2,532
-34% -$156K 0.01% 329
2020
Q1
$406K Buy
+7,392
New +$496K 0.01% 307

Other funds holding DOX

Ray Dalio's DOX Position: Q1 2026 in Review

Ray Dalio sold out of Amdocs (DOX) in Q1 2026, closing a stake of 249,195 shares — an estimated $20.1M sold.

Ray Dalio first reported a position in DOX in Q1 2020 and held it in 19 quarters. The position peaked at $29.1M in Q2 2025. 474 funds tracked by Wall St. Rank hold DOX as of Q1 2026.

  • Ray Dalio reported no remaining Amdocs position as of Q1 2026 after selling out during the quarter.
  • Ray Dalio sold 249,195 Amdocs shares in Q1 2026, an estimated $20.1M.
  • Ray Dalio first reported a position in Amdocs in Q1 2020 and held it in 19 quarters.
  • Ray Dalio's Amdocs position peaked at $29.1M in Q2 2025.
  • 474 funds tracked by Wall St. Rank held Amdocs as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.